Upgrade Now

Director Share Purchase

By Sharecast

Date: Monday 09 Mar 2026







RNS Number : 9114V
Kromek Group PLC
09 March 2026
 



9 March 2026


 


Kromek Group plc 


("Kromek", the "Company" or the "Group") 


 


Director Share Purchase


 


Kromek (AIM: KMK), a global detection company delivering best-in-class solutions for the advanced imaging and CBRN detection markets, announces that Rakesh Sharma, Non-executive Chairman of the Company, today purchased 102,669 ordinary shares of 1p each in the Company ("Ordinary Shares") at a price of 9.74p per Ordinary Share.


 


Following this purchase, Mr. Sharma holds 1,310,208 Ordinary Shares, representing 0.2% of the Company's issued share capital.


 


 


Enquiries 


 






































Kromek Group plc 






Arnab Basu, CEO 


Claire Burgess, CFO 



+44 (0)1740 626 060 



 






Cavendish Capital Markets Limited (Nominated Adviser and Broker)  



  



Geoff Nash/Giles Balleny/Seamus Fricker - Corporate Finance 


Andrew Burdis - ECM


Michael Johnson - Sales



+44 (0)20 7220 0500 


 









Gracechurch Group (Financial PR) 






Harry Chathli/Claire Norbury



+44 (0)20 4582 3500 



 


Kromek Group plc 


 


Kromek Group plc is a leading developer of radiation detection and bio-detection technology solutions for the advanced imaging and CBRN detection segments. Headquartered in County Durham, UK, Kromek has manufacturing operations in the UK and US, delivering on the vision of enhancing the quality of life through innovative detection technology solutions.  


 


The advanced imaging segment comprises the medical (including CT and SPECT), security and industrial markets. Kromek provides its OEM customers with detector components, based on its core cadmium zinc telluride (CZT) platform, to enable better detection of diseases such as cancer and Alzheimer's, contamination in industrial manufacture and explosives in aviation settings.  


 


 In CBRN detection, the Group provides nuclear radiation detection solutions to the global homeland defence and security market. Kromek's compact, handheld, high-performance radiation detectors, based on advanced scintillation and solid-state readout technology, are primarily used to protect critical infrastructure, events, personnel and urban environments from the threat of 'dirty bombs'.  


 


The Group is also developing bio-security solutions in the CBRN detection segment. These consist of fully automated and autonomous systems to detect a wide range of airborne pathogens.  


 


Kromek is listed on AIM, a market of the London Stock Exchange, under the trading symbol 'KMK'.  


 


Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them


 


 





















































































































1


 



Details of the person discharging managerial responsibilities / person closely associated


 



a)


 



Name


 


 



Rakesh Sharma



2


 



Reason for the notification


 



a)


 



Position/status


 


 



Non-executive Chairman



b)


 



Initial notification /Amendment


 


 



Initial notification



3


 



Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor


 



a)


 



Name


 


 



Kromek Group plc



b)


 



LEI


 


 



213800VLHYXGHEX5VQ48


 



4


 



Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted


 


 



a)


 



Description of the financial instrument, type of instrument



Ordinary shares of 1 penny each









Identification code



GB00BD7V5D43









b)


 



Nature of the transaction


 


 



Purchase of ordinary shares



c)


 



Price(s) and volume(s)





















Price(s)



Volume(s)












9.74p



102,669





















d)


 



 


Aggregated information


 


-      Aggregated volume


 


-      Price


 



 


N/A









e)


 



Date of the transaction


 


 



9 March 2026



f)


 



Place of the transaction


 


 



London Stock Exchange



 


 


 






This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEADDNEDLKEFA

« Go back to news channel

..

Email this article to a friend

or share it with one of these popular networks:


Top of Page